View Cart (0 items)


Valeant Pharmaceuticals acquires Visudyne From QLT

September 24, 2012
MONTREAL — Valeant Pharmaceuticals International, Inc. says it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration,
Read More

Bayer HealthCare to acquire Teva U.S. animal health business

September 18, 2012
SHAWNEE, Kan. and JERUSALEM — Bayer HealthCare LLC and Teva Pharmaceutical Industries Ltd. say they have signed an agreement in which Bayer will acquire the U.S. based animal health
Read More

Valeant Pharmaceuticals to acquire Medicis Pharmaceutical Corp.

September 4, 2012
MONTREAL and SCOTTSDALE, Ariz. — Valeant Pharmaceuticals International and Medicis Pharmaceutical Corp. have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock
Read More

Pharmaceutical company to create 200 jobs in North Carolina

August 30, 2012
RALEIGH, N.C. — Pharmaceutical company Hospira plans to invest at least $85 million over the next three years to modernize and expand its operations in Nash County, N.C., Gov.
Read More

Pascal Soriot appointed CEO of AstraZeneca

August 28, 2012
LONDON — Pascal Soriot has been appointed as AstraZeneca’s chief executive officer, the company announced. Simon Lowth remains as AstraZeneca’s interim CEO until Pascal Soriot joins. At that point,
Read More

Sun Pharma to take Taro private

August 21, 2012
MUMBAI, India and HAWTHORNE, N.Y. — Sun Pharmaceutical Industries Ltd. and Taro Pharmaceutical Industries Ltd. have entered into a merger agreement together with certain affiliates of Sun Pharma. The
Read More

Accenture to acquire Octagon Research Solutions

August 7, 2012
NEW YORK — Accenture has entered into an agreement to acquire Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical
Read More

Global pharmaceutical industry calls for cooperation to fight counterfeit medicines

July 24, 2012
WASHINGTON — The global pharmaceutical industry has unveiled recommendations to tackle the growing public health threat of counterfeit or fake medicines. The industry''s call for increased public awareness and
Read More

DSM announces South American biologics manufacturing contract

July 17, 2012
PARSIPPANY, N.J. — DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. announced a biologics contract manufacturing agreement with its first Brazilian client, RECEPTA Biopharma
Read More

Global spending on medicines to reach nearly $1.2 trillion by 2016

July 17, 2012
PARSIPPANY, N.J. — Following several years of slowing growth, the global market for medicines is poised to rebound from an expected low point of 3% - 4% growth in
Read More